000 | 01953 a2200529 4500 | ||
---|---|---|---|
005 | 20250514075836.0 | ||
264 | 0 | _c20031007 | |
008 | 200310s 0 0 eng d | ||
022 | _a0002-9149 | ||
024 | 7 |
_a10.1016/s0002-9149(03)00721-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBays, Harold E | |
245 | 0 | 0 |
_aEffectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol. _h[electronic resource] |
260 |
_bThe American journal of cardiology _cSep 2003 |
||
300 |
_a538-43 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 |
_aAnticholesteremic Agents _xadministration & dosage |
650 | 0 | 4 |
_aApolipoprotein A-I _xblood |
650 | 0 | 4 |
_aApolipoprotein A-II _xblood |
650 | 0 | 4 |
_aApolipoproteins B _xblood |
650 | 0 | 4 |
_aApolipoproteins C _xblood |
650 | 0 | 4 |
_aApolipoproteins E _xblood |
650 | 0 | 4 |
_aCaproates _xadministration & dosage |
650 | 0 | 4 |
_aCholesterol, HDL _xblood |
650 | 0 | 4 |
_aCholesterol, LDL _xblood |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypercholesterolemia _xblood |
650 | 0 | 4 |
_aHypertriglyceridemia _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTriglycerides _xblood |
700 | 1 | _aMcKenney, James M | |
700 | 1 | _aDujovne, Carlos A | |
700 | 1 | _aSchrott, Helmut G | |
700 | 1 | _aZema, Michael J | |
700 | 1 | _aNyberg, Jack | |
700 | 1 | _aMacDougall, Diane E | |
773 | 0 |
_tThe American journal of cardiology _gvol. 92 _gno. 5 _gp. 538-43 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9149(03)00721-5 _zAvailable from publisher's website |
999 |
_c12713883 _d12713883 |